The WSAVA has hit back at inaccurate reports in the national media claiming it was urging vets to avoid using a market-leading vaccine.

Nobivac-L4Former WSAVA president Michael Day has rebutted The Daily Telegraph’s article claiming the association was recommending vets avoid using MSD’s Nobivac L4 leptospirosis vaccine on puppies younger than 12 weeks.

Describing the statement as “blatantly untrue”, he said: “The WSAVA would never ‘urge owners’ and would never make recommendations about individual named commercial products.”

Prof Day added: “The WSAVA guidelines are available online and this journalist has clearly not undertaken adequate research before publishing this article.”


Several national newspapers picked up on the story, with The Daily Telegraph claiming “regulators have received 2,000 reports of dogs having suspected adverse or fatal reactions” following vaccination with Nobivac L4.

The VMD has received notifications, but a report obtained by Veterinary Times showed, in the three-and-a-half years since the vaccine was authorised, the incidence of adverse reactions was 0.064 per cent. Therefore, for every 10,000 doses sold, six reports of adverse reactions were received.

MSD has been asked to put additional warnings on the product information stating immune-mediated reactions – including immune-mediated haemolytic anaemia, immune-mediated thrombocytopenia and immune-mediated polyarthritis – have been reported in rare cases.

When contacted about the reports, MSD emphasised safety profiles of veterinary pharmaceuticals and vaccines are established from rigorous clinical trials and safety warnings for the product are provided on the product data sheet.

  • Read more on this story in the 18 July issue of Veterinary Times.
View your activity >

Leave a Reply

Be the First to Comment!

Notify of


related content

A poster created by the association with the British Medical Association, Public Health England and the VMD has been shortlisted for an Antibiotic Guardian Award at this year's ceremony in June.

3 mins

New practice in Rubery, Worcestershire hosted more than 100 pet owners from the local community for the day, where a charity raffle for The Cinnamon Trust also took place.

2 mins

The European Commission has granted marketing authorisation for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European Union for veterinary use.

3 mins

A “disproportionately high” number of vets reported to have experienced adverse events from the use of authorised veterinary medicines were female, according to the latest pharmacovigilance report from the VMD.

5 mins

The Worldwide Veterinary Service has until August to raise £250,000 to retain its Care for Dogs shelter in northern Thailand.

3 mins

Catherine Bovens discusses various methods of diagnosis and treatment for this common autoimmune disease present in dogs.

37 mins